Yeah great to hear from the CEO that everything is still on track:
"These covenant changes allow Orchids to focus on its business plan to increase production and sales significantly in the second half of 2017. The new business we announced in January is on track to begin shipping in late May with full implementation by July 1."
The Q1 report next week won't be pretty. Maybe we'll get one last buying opportunity. But the market looks forward, not backward. Outlook for Q2 and beyond should be very bullish. With revenues & earnings starting to ramp higher in the current quarter, I would expect the stock to move solidly higher soon. TIS popped over $30 after the Q4 report in February. And Q4 was a poor quarter! A return to $30 later this year would be a 30% gain from here. And if business ramps up like management expects, I wouldn't be surprised to see $35 or even $40 by yearend.
News 
Market Data 
Discover 
